US Business

The agency unveiled proposed rules for menthol cigarettes and flavored cigars that could sweep from the market more than a third of all cigarettes sold in the U.S. The plan wouldn’t take effect for at least two years.

U.S. health regulators approved a pill from Bristol-Myers Squibb, the first to treat a genetic heart disease that is the most common cause of sudden cardiac death in people under age 35.

The iPhone maker posted better-than-expected results for its latest quarter but warned that supply-chain disruptions remain a significant challenge.

The tech giant has seen a shopping slump and cost increases due to inflation, labor issues and supply chain challenges, while its stake in electric vehicle maker Rivian also weighed on results.

The crew members are slated to conduct scientific research in a mission that comes as the billionaire prepares to add Twitter to his company roster.

Tesla CEO wins a major victory in case where shareholders alleged he controlled the takeover and overpaid for the solar-energy company.

The toy maker’s chief executive declined to comment on a Wall Street Journal report that the toy maker has discussed potential sale with private-equity firms.

The social-media company reported its slowest growth since going public a decade ago, but daily active users increased and net income was better than expected.

Under pressure from the FAA, the plane maker increased scrutiny of its manufacturing. The result has been a string of Dreamliner delays that have become headaches for both Boeing and the airlines waiting for delivery. “What happens when you take a microscope to anything?”

Cloud investments aimed at catching Amazon and Microsoft weighed on the tech giant’s bottom line. Alphabet shares fell after hours.